Semaglutide 10 mg

Description

Semaglutide 10 mg — Product Description

Product Name: Semaglutide 10 mg
Active Ingredient: Semaglutide (glucagon-like peptide-1 receptor agonist)

What it is:
Semaglutide is a prescription medicine in the GLP-1 receptor agonist class. It mimics the naturally occurring hormone GLP-1 to help the body manage blood sugar levels and supports appetite control.

How it Works:

• Stimulates insulin secretion when glucose levels are high
• Reduces the amount of glucagon released
• Slows gastric emptying
• Helps reduce appetite and food intake

Indications / Uses:

• Type 2 Diabetes Mellitus: As an adjunct to diet and exercise to improve blood glucose control.
• Cardiovascular Risk Reduction: May help reduce the risk of major cardiovascular events (e.g., heart attack, stroke) in adults with type 2 diabetes and known heart disease.
• Weight Management / Obesity: In appropriate patient populations, semaglutide supports chronic weight loss and maintenance when used with diet and exercise

Formulation & Administration:
Semaglutide is typically supplied as a pre-filled subcutaneous injection pen. The medication is injected once weekly under the skin of the abdomen, thigh, or upper arm, with or without food.
(Note: A “10 mg” version refers to the total semaglutide content in a vial or pen cartridge intended for weekly dosing when titrated under medical supervision.)

Safety and Side Effects:
Common side effects primarily involve the gastrointestinal system and may include nausea, vomiting, diarrhea, constipation, and abdominal discomfort.

Serious and less common risks include hypersensitivity reactions and issues related to delayed gastric emptying. A boxed warning (in some regions) alerts to potential thyroid C-cell tumor risk based on animal studies.

Important Notes:

• Semaglutide should be used exactly as prescribed by a healthcare provider.
• It is not a cure for diabetes or obesity; ongoing lifestyle modifications are essential.
• Use may require gradual dose escalation to improve tolerability.